Entelos stages comeback bid with funding

Back out of bankruptcy, modeling and simulation software company Entelos has recapitalized its business and brought on a new investor, the San Mateo, CA-based company said last week. The company, which emerged from bankruptcy in September, provides predictive technologies that aid in the development of drugs, healthcare products, foods and consumer products. Private equity investors Clearlake Capital Group and Imperium Partners Group are backing Entelos in its recent financing. The new funding will be used for product development and marketing efforts, according to the company. Article | Release

Sponsored By Metabolon

Five Translational Insights Key to a Successful First-in-Human (FIH) Study – Metabolite-Based Biomarker Discovery and Validation

Translational success rates from pre-clinical animal studies to human clinical trials remain frustratingly low. Learn how metabolomics helps you bridge between the theoretical & practical, between the function & actual activity of your drug molecule to get you closer to the phenotype, sooner.